In a previous study, Hu et al found that CCL5 is a reliable biomarker for predicting liver fibrosis and cirrhosis: the expression of CCL5 in serum and hepatic tissue first increased in CHB patients with ongoing liver injury and then significantly decreased in advanced liver cirrhosis patients.20 This evidence concerns the gene CCL5 and cirrhosis of liver.